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Background
Increasing interest has focused on the relative functional-
ity of high-density lipoprotein (HDL), highlighted by
observations that cardiovascular events can occur even in
the presence of high levels of HDL cholesterol. Myeloper-
oxidase (MPO), a heme protein abundant in leucocytes,
colocalizes with HDL in the human artery wall and has
emerged as a potential participant in multiple phases of
the atherosclerotic process. Recently, the MPO/H2O2/
SCN- system has been demonstrated as a dominant path-
way to promote protein carbamylation within atheroscle-
rotic plaques. Therefore, we determined whether HDL is
carbamylated in the human artery wall.
Methods and results
Immunohistochemical studies confirmed colocalization
of carbamylated epitopes with apoA-I and macrophages
in human atherosclerotic lesions. We performed shotgun
proteomic analysis of in vitro carbamylated HDL to iden-
tify specific carbamylation sites of apoA-I. We could iden-
tify apoA-I-associated lysine residues in the α-helical lipid
binding domains that are specifically carbamylated, indi-
cating that carbamylation of apoA-I affects the functional
integrity of HDL. In line with this observation, we
observed that carbamylation of HDL (i) leads to "non-
productive" binding to the HDL receptor (SR-BI), (ii)
decreased SR-BI-mediated cholesterol efflux, and (iii)
reduced HDL mediated anti-inflammatory activity.
Conclusion
Taken together, our data provide strong evidence that car-
bamylation renders HDL dysfunctional and proinflam-
matory.
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